IC
NVAX icon

Ikarian Capital’s Novavax NVAX Stock Holding History

Ikarian Capital’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-913,200
Closed -$4.38M – 170
2023
Q4 		$4.38M Buy
913,200
+901,068
+7,427% +$5.52M 0.41% 66
2023
Q3 		$8.78M Sell
12,132
-387,868
-97% -$3.1M 1.06% 30
2023
Q2 		$2.97M Buy
+400,000
New +$3.15M 0.47% 53
2021
Q2 		– Sell
-195,700
Closed -$35.5M – 262
2021
Q1 		$35.5M Sell
195,700
-128,000
-40% -$25.5M 1.19% 19
2020
Q4 		$36.1M Sell
323,700
-51,700
-14% -$5.5M 1.59% 11
2020
Q3 		$40.7M Buy
375,400
+211,100
+128% +$25.7M 2.94% 6
2020
Q2 		$13.7M Buy
+164,300
New +$6.28M 1.09% 28

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ikarian Capital's NVAX Position: Q2 2022 in Review

Ikarian Capital sold out of Novavax (NVAX) in Q2 2022, closing a stake of 1,362 shares — an estimated $100K sold.

Ikarian Capital first reported a position in NVAX in Q4 2019 and held it in 8 quarters. The position peaked at $559K in Q2 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • Ikarian Capital reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • Ikarian Capital sold 1,362 Novavax shares in Q2 2022, an estimated $100K.
  • Ikarian Capital first reported a position in Novavax in Q4 2019 and held it in 8 quarters.
  • Ikarian Capital's Novavax position peaked at $559K in Q2 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Ikarian Capital's 13F filing for Q2 2022, filed 12 Aug 2022.